DMRADamora Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Damora Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMRAEsta | $1.3B#5 | 2.8x#1 | 2.6x#5 | — | — | -878.8%#10 | — | -40.7%#8 | — | — | 189.9%#1 | — |
| OCUL | $1.5B#1 | — | 2.8x#7 | 28.5x#6 | -18.5%#5 | -37.4%#6 | -519.8%#6 | -51.1%#9 | — | — | -42.2%#9 | — |
| PCRX | $1.5B#3 | 104.0x#3 | 2.2x#2 | 2.0x#1 | 3.6%#3 | 107.0%#1 | 2.6%#1 | 1.0%#1 | 1.0%#1 | — | 70.1%#4 | — |
| ETON | $1.5B#2 | — | 31.2x#10 | 18.2x#5 | 104.9%#2 | -20.4%#5 | -1.1%#2 | -9.9%#4 | -1.8%#2 | 4#1 | 181.6%#2 | — |
| MLYS | $1.4B#4 | — | 2.5x#4 | — | — | 13.0%#3 | — | -28.1%#6 | -41.3%#4 | — | -62.0%#10 | — |
| KARD | $1.3B#6 | — | 2.2x#3 | — | — | — | — | 0.0%#2 | — | — | — | — |
| OMER | $1.3B#8 | 10.3x#2 | — | 17.5x#4 | -34.0%#6 | 97.9%#2 | -166.4%#5 | — | -151.8%#6 | — | 143.4%#3 | — |
| OPK | $1.3B#7 | — | 1.1x#1 | 2.1x#2 | -14.9%#4 | -324.0%#9 | -19.3%#3 | -19058.1%#10 | -13.3%#3 | 4#1 | 27.7%#6 | — |
| TYRA | $1.3B#9 | — | 3.6x#9 | — | — | -38.7%#7 | — | -33.9%#7 | — | — | 34.9%#5 | — |
| RAPP | $1.2B#10 | — | 2.8x#8 | — | — | -42.4%#8 | — | -26.4%#5 | — | — | -13.1%#8 | — |
| SNDX | $1.2B#11 | — | — | 6.8x#3 | 627.8%#1 | 10.5%#4 | -158.4%#4 | — | -143.0%#5 | — | -4.6%#7 | — |
| AVLN | $1.1B#12 | — | 2.8x#6 | — | — | — | — | 0.0%#2 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice